NAGE NAGE Advertising

Advertising at other companies

USANA Health SciencesUSNA

$10.79M+769%

John B. Sanfilippo & SonJBSS

$2.77M-29.3%

Consumer Products segment$3.29M+10.6%

Analytical Reference Standards and Services segment$0—

Ingredients segment$0—

Pharmaceuticals segment$0—

Revenue$31.5M+3.3%

Gross profit$20.0M+3.3%

Operating income$1.6M-67.0%

Net income$6.3M+24.8%

EPS (diluted)$0.07+16.7%

Cash & equivalents$66.5M+19.7%

Total debt$2.6M-26.9%

Total equity$82.3M+48.8%

Total assets$114.3M+40.6%

Operating cash flow-$1.2M-115%

Market cap$254.07M-74.9%

Enterprise value$190.09M-79.7%

P/E13.6×-43.5×

P/S2×-6.8×

Gross margin64.3%+1.8pp

Operating margin10%-2.2pp

Net margin14.3%+1.2pp

FCF margin-70.4%—

Return on equity27.1%-6.4pp

Debt / equity0×0.0×

Current ratio4.6×+0.9×